Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
EXAMINE Trial Post-Hoc Analyses of Mortality Data Regarding Cardiovascular Safety of Alogliptin Presented at American Diabetes Association's 76th Scientific Sessions and Published in Diabetes Care 2016-06-12 11:10
ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV 2016-06-10 21:44
ProPak Asia 2016 -- Connecting the World to AEC in Thailand 2016-06-10 15:40
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs 2016-06-09 18:45
Patient-reported Outcomes across Phase 3 studies of Baricitinib demonstrate Statistically Significant Improvements in Physical Function and Quality of Life Symptoms in Patients with Rheumatoid Arthritis (RA) 2016-06-09 18:45
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders 2016-06-08 21:02
Disruptive Technologies and Emerging Trends Drive Life Science Transformation 2016-06-07 21:05
Results of Clinical and Patient-Reported Outcomes Data for Baricitinib in Patients with Rheumatoid Arthritis to be Presented at Annual European Congress of Rheumatology (EULAR 2016) 2016-06-07 19:00
Takeda to Present New Data at the American Diabetes Association's 76th Scientific Sessions 2016-06-07 01:09
Finesse SmartFactory(TM) Platform Featured in Alvotech Opening of New Manufacturing and Lab Facility in Iceland 2016-06-06 21:00
SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment 2016-06-06 20:54
Daiichi Sankyo to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on Thursday, June 9th, 2016 2016-06-06 20:30
Hutchison China MediTech to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on June 10, 2016 2016-06-06 20:30
Merck Partners with Array BioPharma and Pierre Fabre to Initiate BRAF-mutant CRC Phase III Trial 2016-06-06 08:05
ADI-PEG 20 plus Gemcitabine and nab-Paclitaxel Shows Robust Anti-tumor Activity in Advanced Pancreatic Cancer 2016-06-03 22:00
Aptuit Names Henning Steinhagen as EVP Drug Discovery and Development, and Site-Head Verona 2016-06-01 08:00
Governments on Track to Eliminate Viral Hepatitis by 2030 2016-05-31 09:00
WHO Recommends Rapid Test for Extensively Resistant Tuberculosis 2016-05-30 15:15
NUS Engineering team develops novel technology to "print" customised tablets for personalised medicine 2016-05-26 12:08
PharmaBlock Listed on the New Third Board and Plans to File for the GEM Exchanges at the End of 2016 2016-05-25 09:00
1 240 241 242 243 244 247